Anales de la RANM

201 A N A L E S R A N M R E V I S T A F U N D A D A E N 1 8 7 9 INFECCIÓN POR HANTAVIRUS Bouza E, et al. An RANM. 2026;143(01): 182 - 206 does not predict the long-term outcome of pa- tients. Nephron Clin Pract. 2010;116(2):c89-94. 120. Settergren B. Clinical aspects of nephropathia epidemica (Puumala virus infection) in Europe: a review. Scand J Infect Dis. 2000;32(2):125-32. 121. Tietäväinen J, Mäkelä S, Huhtala H, Pörsti IH, Strandin T, Vaheri A, et al. The Clinical Pre- sentation of Puumala Hantavirus Induced He- morrhagic Fever with Renal Syndrome Is Rela- ted to Plasma Glucose Concentration. Viruses. 2021;13(6). 122. Puljiz I, Kuzman I, Markotić A, Turcinov D, Matić M, Makek N. Electrocardiographic changes in patients with haemorrhagic fe- ver with renal syndrome. Scand J Infect Dis. 2005;37(8):594-8. 123. Makela S, Kokkonen L, Ala-Houhala I, Groundstroem K, Harmoinen A, Huhtala H, et al. More than half of the patients with acute Puumala hantavirus infection have ab- normal cardiac findings. Scand J Infect Dis. 2009;41(1):57-62. 124. Markotić A, Nichol ST, Kuzman I, Sanchez AJ, Ksiazek TG, Gagro A, et al. Characteristics of Puumala and Dobrava infections in Croatia. J Med Virol. 2002;66(4):542-51. 125. Hukić M, Valjevac A, Tulumovic D, Numano- vic F, Heyman P. Pathogenicity and virulence of the present hantaviruses in Bosnia and Her- zegovina: the impact on renal function. Eur J Clin Microbiol Infect Dis. 2011;30(3):381-5. 126. Hukić M, Muzaferović S, Tulumović D, Calkić L, Sabović S, Karakas S, et al. [Puumala and Dobrava viruses in the northeastern and cen- tral regions of Bosnia]. Acta Med Croatica. 2003;57(5):373-80. 127. Takeuchi T, Yamamoto T, Itoh M, Tsukada K, Yasue N, Lee HW. Clinical studies on hemorr- hagic fever with renal syndrome found in Na- goya City University Medical School. Kidney Int Suppl. 1991;35:S84-7. 128. Miettinen MH, Mäkelä SM, Ala-Houhala IO, Huhtala HS, Kööbi T, Vaheri AI, et al. Ten- year prognosis of Puumala hantavirus-indu- ced acute interstitial nephritis. Kidney Int. 2006;69(11):2043-8. 129. Lähdevirta J, Collan Y, Jokinen EJ, Hiltunen R. Renal sequelae to nephropathia epidemica. Acta Pathol Microbiol Scand A. 1978;86(4):265-71. 130. Armien B, Pascale JM, Munoz C, Lee SJ, Choi KL, Avila M, et al. Incidence rate for hantavirus infections without pulmonary syndrome, Pana- ma. Emerg Infect Dis. 2011;17(10):1936-9. 131. Alonso DO, Iglesias A, Coelho R, Periolo N, Bruno A, Córdoba MT, et al. Epidemiologi- cal description, case-fatality rate, and trends of Hantavirus Pulmonary Syndrome: 9 years of surveillance in Argentina. J Med Virol. 2019;91(7):1173-81. 132. MacNeil A, Ksiazek TG, Rollin PE. Hantavirus pulmonary syndrome, United States, 1993- 2009. Emerg Infect Dis. 2011;17(7):1195-201. 133. Ferrés M, Martínez-Valdebenito C, Henriquez C, Marco C, Angulo J, Barrera A, et al. Viral shedding and viraemia of Andes virus during acute hantavirus infection: a prospective study. Lancet Infect Dis. 2024;24(7):775-82. 134. Castillo C, Naranjo J, Sepúlveda A, Ossa G, Levy H. Hantavirus pulmonary syndrome due to An- des virus in Temuco, Chile: clinical experience with 16 adults. Chest. 2001;120(2):548-54. 135. Noack D, Goeijenbier M, Reusken C, Koo- pmans MPG, Rockx BHG. Orthohantavirus Pathogenesis and Cell Tropism. Front Cell In- fect Microbiol. 2020;10:399. 136. Riquelme R, Riquelme M, Torres A, Rioseco ML, Vergara JA, Scholz L, et al. Hantavirus pulmonary syndrome, southern Chile. Emerg Infect Dis. 2003;9(11):1438-43. 137. Passaro DJ, Shieh WJ, Hacker JK, Fritz CL, Ho- gan SR, Fischer M, et al. Predominant kidney involvement in a fatal case of hantavirus pul- monary syndrome caused by Sin Nombre virus. Clin Infect Dis. 2001;33(2):263-4. 138. Pergam SA, Schmidt DW, Nofchissey RA, Hunt WC, Harford AH, Goade DE. Potential renal sequelae in survivors of hantavirus cardio- pulmonary syndrome. Am J Trop Med Hyg. 2009;80(2):279-85. 139. Sotomayor PV, Olea NA, Labraña AM, Castillo HC, Ortega RC, Riquelme OR, et al. [Diagnosis and treatment of cardiopulmonary hantavirus syndrome: Chile-2007]. Rev Chilena Infectol. 2009;26(1):68-86. 140. Gracia F, Armien B, Simpson SQ, Munoz C, Broce C, Pascale JM, et al. Convalescent pul- monary dysfunction following hantavirus pul- monary syndrome in Panama and the United States. Lung. 2010;188(5):387-91. 141. Valenzuela G, Barahona K, Rojas C, Barrera A, Henríquez C, Martínez-Valdebenito C, et al. Beyond ECMO Survival: Long-Term Symp- tom Burden and Quality-of-Life Impairment in Hantavirus Cardiopulmonary Syndrome Survi- vors. Viruses. 2025;17(9). 142. Alexeyev OA, Baranov BA. Puumala virus in- fection without signs of renal involvement. Scand J Infect Dis. 1993;25(4):525-7. 143. van Ypersele de Strihou C, van der Groen G, Desmyter J. Hantavirus nephropathy in Wes- tern Europe: ubiquity of hemorrhagic fevers with renal syndrome. Adv Nephrol Necker Hosp. 1986;15:143-72. 144. Dusek J, Pejcoch M, Kolsky A, Seeman T, Ne- mec V, Stejskal J, et al. Mild course of Puumala nephropathy in children in an area with spo- radic occurrence Hantavirus infection. Pediatr Nephrol. 2006;21(12):1889-92. 145. Ferluga D, Vizjak A. Hantavirus nephropathy. J Am Soc Nephrol. 2008;19(9):1653-8. 146. Demeester R, Bottieau E, Van Esbroeck M, Pourkarim MR, Maes P, Clement J. Hantavi- rus nephropathy as a pseudo-import pathology from Ecuador. Eur J Clin Microbiol Infect Dis. 2010;29(1):59-62. 147. Murray KO, Fischer RS, Chavarria D, Dutt- mann C, Garcia MN, Gorchakov R, et al. Me- soamerican nephropathy: a neglected tropical disease with an infectious etiology? Microbes Infect. 2015;17(10):671-5. 148. Armién B, Muñoz C, Cedeño H, Salazar JR, Sa- linas TP, González P, et al. Hantavirus in Pa- nama: Twenty Years of Epidemiological Survei- llance Experience. Viruses. 2023;15(6).